dm+d
108418007
Articles
How should medicines be dosed in children who are obese?
28 May 2021Review on how to calculate medicine doses in children who are obese which includes a table on commonly prescribed medicines.
What injections can be given orally or via enteral feeding tubes?
6 November 2020This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…
Medicine Compliance Aid Stability
ZofranNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Zofran
Tablets f/c 4mg, 8mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light and store in airtight containers.
22 November 2022
Zofran MeltNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Zofran Melt
Oral lyophilisates 4mg, 8mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Tablet designed to dissolve on tongue - unsuitable for MCA
22 November 2022
Lactation Safety Information
Alternative anti-emetic if appropriate
5HT3-receptor antagonist
No published evidence of safety
Used in infants > 1 month
15 July 2019